Literature DB >> 30771421

Drugs used for neurologic and psychiatric conditions increase the risk for bullous pemphigoid: A case-control study.

Outi Varpuluoma1, Jari Jokelainen2, Anna-Kaisa Försti1, Miia Turpeinen3, Markku Timonen4, Laura Huilaja5, Kaisa Tasanen1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30771421     DOI: 10.1016/j.jaad.2019.02.017

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

1.  Association Between Medication Use and Bullous Pemphigoid: A Systematic Review and Meta-analysis.

Authors:  Sian-De Liu; Wei-Ti Chen; Ching-Chi Chi
Journal:  JAMA Dermatol       Date:  2020-08-01       Impact factor: 10.282

Review 2.  Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid.

Authors:  Kaisa Tasanen; Outi Varpuluoma; Wataru Nishie
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 8.786

Review 3.  Depression and Anxiety in Patients with Bullous Pemphigoid: Impact and Management Challenges.

Authors:  Nicolas Kluger; Anna Pankakoski; Jaana Panelius
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-01-21

Review 4.  Bullous Pemphigoid: Trigger and Predisposing Factors.

Authors:  Francesco Moro; Luca Fania; Jo Linda Maria Sinagra; Adele Salemme; Giovanni Di Zenzo
Journal:  Biomolecules       Date:  2020-10-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.